Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05805709 · ClinicalTrials.gov registry record · NA
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
A NA study of Acute Kidney Injury, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 2,145
- Enrollment target
- 9
- Study locations
NCT05805709 is a NA study of Acute Kidney Injury that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 2,145 participants, roughly in line with the 2,302-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target. The trial reports 9 study locations across 6 states.
The verdict
NCT05805709, a NA study of Acute Kidney Injury, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,145 participants
- Enrollment target
- 9
- Study locations
Study Summary
The COPE-AKI study is a randomized, pragmatic, parallel-arm trial comparing a multimodal intervention to usual care on hospital-free days through 90 days of study follow up. The primary study hypothesis is that patients randomized to the intervention will have increased odds of more hospital-free days through 90 days (primary clinical) compared to those randomized to usual care. Key secondary hypotheses will investigate the impact of the intervention on rates of major adverse kidney events, rates of recurrent AKI, and changes in patient-reported outcomes. Participants (N=2145) will be allocated 1:1 to the intervention or usual care using a web-based system to maintain allocation concealment using stratified randomization with randomly permuted blocks. Randomization will be stratified by clinical site.
Conditions Studied
Interventions
- OTHER Patient Education
- OTHER Study Physician/Advance Practice Provider
- OTHER Nurse Navigator
- OTHER Pharmacist
Study Locations (9)
Maryland
- University of Maryland - Baltimore
- Johns Hopkins University - Baltimore
Ohio
- MetroHealth - Cleveland
- Cleveland Clinic Foundation - Cleveland
Tennessee
- Nashville VA Medical Center - Nashville
- Vanderbilt University - Nashville
Alabama
- University of Alabama at Birmingham - Birmingham
Connecticut
- Yale University - New Haven
Florida
- Cleveland Clinic Weston Hospital - Weston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,145 participants |
| Start Date | 2023-09-05 |
| Est. Completion | 2027-03-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05805709
The ClinicalTrials.gov registry entry for NCT05805709 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,145 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,302-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Kidney Injury appearing as the primary indexed condition, and to 4 interventions - of which Patient Education is the first listed.
NCT05805709 reports 9 study locations spanning 6 distinct geographic areas - top geographies include Maryland, Ohio, Tennessee.
Frequently Asked Questions
What is clinical trial NCT05805709 about?
NCT05805709 is a clinical study titled "A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial". The COPE-AKI study is a randomized, pragmatic, parallel-arm trial comparing a multimodal intervention to usual care on hospital-free days through 90 days of study follow up. The primary study hypothesis is that patients randomized to the intervention will have increased odds of more hospital-free da...
What is the current status of trial NCT05805709?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,145 participants. The study started on 2023-09-05. Estimated completion is 2027-03-05.
What conditions does trial NCT05805709 study?
This clinical trial studies the following conditions: Acute Kidney Injury.
What interventions are being tested in trial NCT05805709?
The interventions under investigation include: Patient Education (OTHER), Study Physician/Advance Practice Provider (OTHER), Nurse Navigator (OTHER), Pharmacist (OTHER).
Who is sponsoring clinical trial NCT05805709?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05805709 being conducted?
This trial has 9 study locations across Alabama, Connecticut, Florida, Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
-
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
RECRUITING · NA
-
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
RECRUITING · NA
-
CTSN Embolic Protection Trial
RECRUITING · NA
-
A Study of Facilitators and Barriers to Improve Acute Kidney Injury in Children Through Mobile Health Intervention
RECRUITING · NA
-
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.